Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs34274351 | chr2:242561110 | A/G | 3.79E-5 | 173 | 24.52 | 28.42 | 20.2 | KM Plot |
PCPG | rs34279974 | chr14:74374584 | G/A | 1.16E-5 | 176 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs34288706 | chr1:40520087 | A/G | 0.000312 | 175 | 25.2 | 27.78 | 25.17 | KM Plot |
PCPG | rs34309159 | chr10:134419166 | C/T | 0.000313 | 172 | 25 | 25.97 | 2.23 | KM Plot |
PCPG | rs34316788 | chr2:242546363 | C/T | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs34317806 | chr2:242537419 | A/G | 2.99E-5 | 176 | 25.87 | 27.27 | 20.28 | KM Plot |
PCPG | rs34325511 | chr4:10028867 | G/A | 0.000211 | 170 | 25.53 | 25.33 | 15 | KM Plot |
PCPG | rs34327448 | chr17:50261956 | A/T | 4.67E-5 | 171 | 25.77 | 28.47 | 14.43 | KM Plot |
PCPG | rs34341642 | chr12:53503606 | TG/T | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs34345010 | chr14:74340605 | G/A | 9.6E-6 | 178 | 25.47 | 28.3 | 10.3 | KM Plot |
PCPG | rs34349450 | chr2:242596715 | T/TTG | 6.19E-11 | 175 | 25.87 | 24.85 | 10.3 | KM Plot |
PCPG | rs34353375 | chr14:74644183 | AAT/A | 0.000221 | 176 | 25.28 | 26.57 | 10.57 | KM Plot |
PCPG | rs34357414 | chr2:24310827 | G/C | 0.00011 | 178 | 25.17 | 27.27 | 17.43 | KM Plot |
PCPG | rs34361545 | chr22:21299225 | GGC/G | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs34363032 | chr16:1714145 | C/T | 0 | 178 | 25.53 | 18.75 | 2.93 | KM Plot |